James J. O'Leary - 01 Feb 2022 Form 4 Insider Report for Fusion Pharmaceuticals Inc.

Role
Chief Medical Officer
Signature
/s/Maria Stahl as Attorney-in-Fact for James O'Leary
Issuer symbol
N/A
Transactions as of
01 Feb 2022
Net transactions value
$0
Form type
4
Filing time
03 Feb 2022, 18:38:34 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FUSN Common Stock Award +1,722 +574% 2,022 31 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FUSN Stock Option (Right to Buy) Award $0 +159,000 $0.000000 159,000 01 Feb 2022 Common Stock 159,000 $7.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased pursuant to the issuer's 2020 Employee Stock Purchase Plan.
F2 This option vests in 48 equal monthly installments beginning on March 1, 2022.